MT Newswires Live04:51
Liminatus Pharma (LIMN) reported late Tuesday a 1-for-50 reverse stock split, with shares to begin trading on a split-adjusted basis at the market open on Aug. 21.
Every 50 shares will be combined into one share, reducing its shares to about 1.3 million from around 67.2 million, it said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
